S
Symphorna
This company develops safe and scalable multi-target RNA medicines designed to address complex diseases involving multiple biological pathways. Their platform integrates a proprietary, cost-effective delivery system capable of high tissue targeting with a versatile therapeutic engine supporting synergistic combinations of different RNA modalities. This approach aims to create effective RNA therapeutics where traditional single-target drugs have proven insufficient.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops safe and scalable multi-target RNA medicines designed to address complex diseases involving multiple biological pathways. Their platform integrates a proprietary, cost-effective delivery system capable of high tissue targeting with a versatile therapeutic engine supporting synergistic combinations of different RNA modalities. This approach aims to create effective RNA therapeutics where traditional single-target drugs have proven insufficient.